Page 4 - Human Data News Today

LOS ANGELES - Baby Ben Kutschke was diagnosed at three months with spinal muscular atrophy, a rare inherited disorder which is the leading genetic cause of death in infancy globally. It leaves children too weak to walk, talk, swallow or even breathe. So when in 2021 his parents heard about Zolgensma – a one-time therapy costing millions of dollars that...

Scientists have developed a novel method for storing biological materials in the form of a pill or a tablet, which dissolves in water for on-demand use. The innovation could overcome current limitations involving in the storage and handling of products derived from living cells used for a variety of health care and scientific research purposes, including pharmaceuticals and diagnostic testing tools.

More than a dozen cancer drugs have been in shortage in recent months, putting patients, particularly women, at risk.

Due to innovative drug development and increasing demand for healthcare, the pharma industry is poised to thrive in the foreseeable future. Given the significant prospects of the industry, pharma stocks...

Despite diversity being spoken about more than ever before, research discovers clinical trials are less representative of the US population compared to a decade prior.

As antibiotic resistance increases globally, antibiotic innovation is struggling. WHO states that the antibiotic clinical pipeline is “insufficient to tackle the challenge of increasing emergence and spread of antimicrobial resistance”.1 To prevent the development of resistance, new antibiotics are used as last resort treatments and, if properly used, have small patient populations, resulting in fairly low sales revenues for industry.

CAMBRIDGE, Mass., Dec. 09, 2022Inc. (Nasdaq: BIIB) - announced that the U.S. Food and Drug Administration (FDA) has accepted for review the abbreviated Biologics License Application (aBLA) for BIIB800

CNN Editorial Research

>> we think that using what weve done before we should be able to appropriately respond to this current outbreak. >> reporter: and while the variant responsible for this particular outbreak the sudan virus does not currently have a vaccine, trials could start in four to six weeks. >> there are about six candidates, vaccine candidates, available for the sudan ebola virus which are mostly in very early stages of development, but three of them have some human data, some immunogenicity and safety da...

Biomarker testing isn’t always the standard of care for many people living with cancer today. Providers and patients need to be better...